Piersma Aldert H
Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands.
Basic Clin Pharmacol Toxicol. 2006 May;98(5):427-31. doi: 10.1111/j.1742-7843.2006.pto_373.x.
Alternatives to animal testing in developmental toxicology have been the subject of three decades of research. The aims of these investigations have been to reduce animal experimentation, to refine effect assessment and mechanistic studies, and to accelerate and simplify safety testing in an area of toxicology that uses relatively many animals. Many alternatives have been developed over the years with different compexities, using biologic material ranging from continuous cell lines to complete embryos. The validation of alternatives and their application in testing strategies is still in its infancy, although significant steps towards these aims are currently being made. The introduction of the genomics technology is a promising emerging area in developmental toxicity testing in vitro. Future application of alternatives in testing strategies for developmental toxicity may significantly gain from the inclusion of gene expression studies, given the unique programme of gene expression changes in embryonic and foetal development.
发育毒理学中动物实验的替代方法已成为三十年研究的主题。这些研究的目的是减少动物实验,完善效应评估和机制研究,并在使用相对较多动物的毒理学领域加速和简化安全性测试。多年来已开发出许多具有不同复杂性的替代方法,使用的生物材料范围从连续细胞系到完整胚胎。替代方法的验证及其在测试策略中的应用仍处于起步阶段,尽管目前正在朝着这些目标迈出重要步伐。基因组学技术的引入是体外发育毒性测试中一个有前景的新兴领域。鉴于胚胎和胎儿发育中基因表达变化的独特程序,未来替代方法在发育毒性测试策略中的应用可能会因纳入基因表达研究而显著受益。